TLR2 and Parkinson disease: Moreover, candesartan cilexetil showed inhibitory effects on TLR2 and TLR4 expression and proinflammatory cytokine secretion like TNF-α, IL-6, and IL-1β, both in primary human monocyte and mice models of PD [142].